capital · May 20, 2026
PathAI Acquisition by Roche Reaches Up to $1.05 Billion
Share the canonical public link.
Roche agreed to acquire PathAI for up to $1.05 billion with $750 million upfront and $300 million in milestones as of May 17, 2026 reporting. PathAI, with 200 employees, uses AI for digital pathology diagnoses and had raised $255 million previously. The deal builds on a five-year partnership and closes in the second half of 2026. PathAI had raised $255 million in venture capital to date.
Below validation threshold — auto-passed without scoring